Deoxyspergualin in relapsing and refractory Wegener's granulomatosis

Annals of the Rheumatic Diseases
Oliver FlossmannDavid R W Jayne

Abstract

Conventional therapy of Wegener's granulomatosis with cyclophosphamide and corticosteroids is limited by incomplete remissions and a high relapse rate. The efficacy and safety of an alternative immunosuppressive drug, deoxyspergualin, was evaluated in patients with relapsing or refractory disease. A prospective, international, multicentre, single-limb, open-label study. Entry required active Wegener's granulomatosis with a Birmingham vasculitis activity score (BVAS) > or =4 and previous therapy with cyclophosphamide or methotrexate. Immunosuppressive drugs were withdrawn at entry and prednisolone doses adjusted according to clinical status. Deoxyspergualin, 0.5 mg/kg per day, was self-administered by subcutaneous injection in six cycles of 21 days with a 7-day washout between cycles. Cycles were stopped early for white blood count less than 4000 cells/mm(3). The primary endpoint was complete remission (BVAS 0 for at least 2 months) or partial remission (BVAS <50% of entry score). After the sixth cycle azathioprine was commenced and follow-up continued for 6 months. 42/44 patients (95%) achieved at least partial remission and 20/44 (45%) achieved complete remission. BVAS fell from 12 (4-25), median (range) at baseline to 2 (0-14...Continue Reading

Citations

Aug 12, 2009·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Bart SpaetgensJan Willem Cohen Tervaert
Dec 25, 2009·Rheumatology·Oliver Flossmann, David R W Jayne
Feb 5, 2011·Rheumatology·Eleana NtatsakiRichard A Watts
Apr 19, 2011·International Journal of Evidence-based Healthcare·Lisa S JeffsChen Au Peh
Jul 5, 2011·Arthritis Research & Therapy·Julia U HolleWolfgang L Gross
May 10, 2012·Arthritis Research & Therapy·Rona M SmithDavid R W Jayne
Jun 3, 2014·BMC Musculoskeletal Disorders·Helena MarcoDavid R W Jayne
Feb 7, 2014·Rheumatology·Miklos PerenyeiOliver Floßmann
Apr 2, 2010·Pediatric Nephrology : Journal of the International Pediatric Nephrology Association·Joannis VamvakopoulosLorraine Harper
Sep 10, 2013·Clinical and Experimental Nephrology·David Jayne
Mar 14, 2013·Expert Opinion on Medical Diagnostics·Alina Casian, David Jayne
Oct 24, 2014·Annual Review of Medicine·Lindsay Lally, Robert Spiera
Dec 15, 2010·Kidney International·Benjamin WildeJan Willem Cohen Tervaert
May 1, 2010·Reumatología clinica·Iñigo Rúa-Figueroa Fernández de Larrinoa, Celia Erausquin Arruabarrena
Jul 30, 2009·APMIS. Supplementum·David Jayne
Oct 1, 2011·Seminars in Ophthalmology·Yvette Marie Santiago, Aaron Fay
Oct 30, 2014·Frontiers in Immunology·Raashid Ahmed Luqmani
Feb 11, 2015·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Raashid Ahmed Luqmani
Aug 11, 2012·Therapeutic Advances in Respiratory Disease·Zulma X YuntKevin K Brown
Aug 2, 2017·Expert Opinion on Investigational Drugs·Adrien MirouseDavid Saadoun
Dec 6, 2017·Zeitschrift für Rheumatologie·Jan Henrik SchirmerFrank Moosig
Aug 3, 2018·Postgraduate Medicine·Bogna Grygiel-GórniakMariusz Puszczewicz
Oct 7, 2010·Nature Reviews. Rheumatology·Min Chen, Cees G M Kallenberg
May 10, 2015·Journal of the American Society of Nephrology : JASN·Marc HilhorstUNKNOWN Limburg Renal Registry
Apr 13, 2017·Journal of the American Society of Nephrology : JASN·David R W JayneUNKNOWN CLEAR Study Group
Jun 28, 2016·F1000Research·Matthew J Koster, Kenneth J Warrington
Jul 31, 2010·Clinical Journal of the American Society of Nephrology : CJASN·David Jayne
Apr 23, 2009·Nature Reviews. Nephrology·Lalit PallanLorraine Harper
Nov 14, 2012·Nature Reviews. Rheumatology·Raashid Luqmani
Oct 17, 2013·Clinical and Experimental Immunology·G A RamirezA A Manfredi
Mar 14, 2012·Current Opinion in Rheumatology·Abraham Rutgers, Cees G M Kallenberg
Feb 2, 2020·European Journal of Internal Medicine·Fernando Salvador
Aug 7, 2010·Rheumatic Diseases Clinics of North America·Julia U HolleWolfgang L Gross
Aug 7, 2010·Rheumatic Diseases Clinics of North America·Abraham RutgersCees G M Kallenberg
Oct 16, 2010·Current Opinion in Ophthalmology
May 24, 2011·Autoimmunity Reviews·Abraham Rutgers, Cees G M Kallenberg

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association
Wilhelm SchmittFokko J van der Woude
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association
Rainer BirckFokko J van der Woude
© 2022 Meta ULC. All rights reserved